Iptacopan for Paroxysmal Nocturnal Hemoglobinuria | NEJM NEJM Group 2:48 5 months ago 2 075 Скачать Далее
ASH 2022: Iptacopan Monotherapy, a Complement Inhibitor of Factor B: Superior to iv Terminal Com... Oncoletter 5:32 1 year ago 1 534 Скачать Далее
Summary of Clinical Trials Testing Novel Treatments for IgAN Leicester IgA Nephropathy 23:05 2 years ago 809 Скачать Далее
Complement inhibition with iptacopan has high efficacy in PNH: insights from APPLY and APPOINT VJHemOnc – Video Journal of Hematology & HemOnc 5:42 3 months ago 190 Скачать Далее
Iptacopan for paroxysmal nocturnal hemoglobinuria VJHemOnc – Video Journal of Hematology & HemOnc 2:21 3 years ago 322 Скачать Далее
TARPEYO Reduces the Loss of Kidney Function in IgA Nephropathy DocWire 9:52 7 months ago 1 649 Скачать Далее
PNH treatment: ravulizumab vs. eculizumab VJHemOnc – Video Journal of Hematology & HemOnc 1:40 5 years ago 4 820 Скачать Далее
What is Complement 3 glomerulopathy (C3G)? | Kidney Disease | American Kidney Fund kidneyfund 2:57 9 months ago 555 440 Скачать Далее
FDA Approves Fabhalta (iptacopan) for Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) Med-Chemist 1:15 1 month ago 46 Скачать Далее
Iptacopan for PNH, Casgevy and Lyfgenia for Sickle Cell Disease, SGT-003 in Duchenne Muscular... Nascent Medical 6:47 8 months ago 400 Скачать Далее
Clinical Trial: Iptacopan (LNP023) for Age-Related Macular Degeneration (NCT05230537) Power Life Sciences 2:02 11 months ago 54 Скачать Далее
New Drugs for Rare Disease Approved by the FDA in 2023 uCan Health 2:08 7 months ago 115 Скачать Далее
Targeting complement to treat PNH and other hematologic diseases VJHemOnc – Video Journal of Hematology & HemOnc 1:51 7 months ago 68 Скачать Далее
NephU – Current Understanding Of IgA Nephropathy (IgAN) NephU Community 7:07 7 months ago 367 Скачать Далее
Complement Controversies Conference Plenary Presentation, "aHUS and C3G" KDIGO 24:27 1 year ago 1 083 Скачать Далее
